Federal Circuit Poised to Shape Future of Pharmaceutical Patents in Upcoming Hearings
The Federal Circuit is slated to hear pivotal arguments this month in several significant patent cases, including those involving Moderna’s COVID-19 vaccine and a major Johnson & Johnson schizophrenia medication. These proceedings highlight ongoing patent law contentions, with potential ramifications for pharmaceutical giants and their market strategies. Additionally, the Federal Circuit will become a point…